MiNK Therapeutics Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.
/ 
Frequently asked questions
To buy MiNK Therapeutics Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for MiNK Therapeutics Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for MiNK Therapeutics Inc. is INKT:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
MiNK Therapeutics Inc. has its primary listing on NASDAQ. You can trade MiNK Therapeutics Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, MiNK Therapeutics Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include MiNK Therapeutics Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like MiNK Therapeutics Inc..